Cargando…

Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy

BACKGROUND: An altered sympathetic nervous system is implicated in many cardiac pathologies, ranging from sudden infant death syndrome to common diseases of adulthood such as hypertension, myocardial ischemia, cardiac arrhythmias, myocardial infarction, and heart failure. Although the mechanisms res...

Descripción completa

Detalles Bibliográficos
Autores principales: Hrabalova, Petra, Bohuslavova, Romana, Matejkova, Katerina, Papousek, Frantisek, Sedmera, David, Abaffy, Pavel, Kolar, Frantisek, Pavlinkova, Gabriela
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114478/
https://www.ncbi.nlm.nih.gov/pubmed/37072781
http://dx.doi.org/10.1186/s12933-023-01824-5
_version_ 1785028023365402624
author Hrabalova, Petra
Bohuslavova, Romana
Matejkova, Katerina
Papousek, Frantisek
Sedmera, David
Abaffy, Pavel
Kolar, Frantisek
Pavlinkova, Gabriela
author_facet Hrabalova, Petra
Bohuslavova, Romana
Matejkova, Katerina
Papousek, Frantisek
Sedmera, David
Abaffy, Pavel
Kolar, Frantisek
Pavlinkova, Gabriela
author_sort Hrabalova, Petra
collection PubMed
description BACKGROUND: An altered sympathetic nervous system is implicated in many cardiac pathologies, ranging from sudden infant death syndrome to common diseases of adulthood such as hypertension, myocardial ischemia, cardiac arrhythmias, myocardial infarction, and heart failure. Although the mechanisms responsible for disruption of this well-organized system are the subject of intensive investigations, the exact processes controlling the cardiac sympathetic nervous system are still not fully understood. A conditional knockout of the Hif1a gene was reported to affect the development of sympathetic ganglia and sympathetic innervation of the heart. This study characterized how the combination of HIF-1α deficiency and streptozotocin (STZ)-induced diabetes affects the cardiac sympathetic nervous system and heart function of adult animals. METHODS: Molecular characteristics of Hif1a deficient sympathetic neurons were identified by RNA sequencing. Diabetes was induced in Hif1a knockout and control mice by low doses of STZ treatment. Heart function was assessed by echocardiography. Mechanisms involved in adverse structural remodeling of the myocardium, i.e. advanced glycation end products, fibrosis, cell death, and inflammation, was assessed by immunohistological analyses. RESULTS: We demonstrated that the deletion of Hif1a alters the transcriptome of sympathetic neurons, and that diabetic mice with the Hif1a-deficient sympathetic system have significant systolic dysfunction, worsened cardiac sympathetic innervation, and structural remodeling of the myocardium. CONCLUSIONS: We provide evidence that the combination of diabetes and the Hif1a deficient sympathetic nervous system results in compromised cardiac performance and accelerated adverse myocardial remodeling, associated with the progression of diabetic cardiomyopathy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-023-01824-5.
format Online
Article
Text
id pubmed-10114478
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-101144782023-04-20 Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy Hrabalova, Petra Bohuslavova, Romana Matejkova, Katerina Papousek, Frantisek Sedmera, David Abaffy, Pavel Kolar, Frantisek Pavlinkova, Gabriela Cardiovasc Diabetol Research BACKGROUND: An altered sympathetic nervous system is implicated in many cardiac pathologies, ranging from sudden infant death syndrome to common diseases of adulthood such as hypertension, myocardial ischemia, cardiac arrhythmias, myocardial infarction, and heart failure. Although the mechanisms responsible for disruption of this well-organized system are the subject of intensive investigations, the exact processes controlling the cardiac sympathetic nervous system are still not fully understood. A conditional knockout of the Hif1a gene was reported to affect the development of sympathetic ganglia and sympathetic innervation of the heart. This study characterized how the combination of HIF-1α deficiency and streptozotocin (STZ)-induced diabetes affects the cardiac sympathetic nervous system and heart function of adult animals. METHODS: Molecular characteristics of Hif1a deficient sympathetic neurons were identified by RNA sequencing. Diabetes was induced in Hif1a knockout and control mice by low doses of STZ treatment. Heart function was assessed by echocardiography. Mechanisms involved in adverse structural remodeling of the myocardium, i.e. advanced glycation end products, fibrosis, cell death, and inflammation, was assessed by immunohistological analyses. RESULTS: We demonstrated that the deletion of Hif1a alters the transcriptome of sympathetic neurons, and that diabetic mice with the Hif1a-deficient sympathetic system have significant systolic dysfunction, worsened cardiac sympathetic innervation, and structural remodeling of the myocardium. CONCLUSIONS: We provide evidence that the combination of diabetes and the Hif1a deficient sympathetic nervous system results in compromised cardiac performance and accelerated adverse myocardial remodeling, associated with the progression of diabetic cardiomyopathy. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s12933-023-01824-5. BioMed Central 2023-04-18 /pmc/articles/PMC10114478/ /pubmed/37072781 http://dx.doi.org/10.1186/s12933-023-01824-5 Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Hrabalova, Petra
Bohuslavova, Romana
Matejkova, Katerina
Papousek, Frantisek
Sedmera, David
Abaffy, Pavel
Kolar, Frantisek
Pavlinkova, Gabriela
Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy
title Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy
title_full Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy
title_fullStr Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy
title_full_unstemmed Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy
title_short Dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy
title_sort dysregulation of hypoxia-inducible factor 1α in the sympathetic nervous system accelerates diabetic cardiomyopathy
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10114478/
https://www.ncbi.nlm.nih.gov/pubmed/37072781
http://dx.doi.org/10.1186/s12933-023-01824-5
work_keys_str_mv AT hrabalovapetra dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy
AT bohuslavovaromana dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy
AT matejkovakaterina dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy
AT papousekfrantisek dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy
AT sedmeradavid dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy
AT abaffypavel dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy
AT kolarfrantisek dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy
AT pavlinkovagabriela dysregulationofhypoxiainduciblefactor1ainthesympatheticnervoussystemacceleratesdiabeticcardiomyopathy